Align Technology (NASDAQ:ALGN) Upgraded at Barclays

Barclays upgraded shares of Align Technology (NASDAQ:ALGN) from an equal weight rating to an overweight rating in a research report sent to investors on Tuesday, Marketbeat.com reports. They currently have $200.00 price objective on the medical equipment provider’s stock.

Other equities research analysts have also issued reports about the stock. Mizuho lifted their target price on shares of Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Jefferies Financial Group raised their price objective on shares of Align Technology from $155.00 to $185.00 and gave the company a “hold” rating in a research report on Thursday, February 5th. Stifel Nicolaus lifted their price objective on shares of Align Technology from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Evercore upped their target price on shares of Align Technology from $180.00 to $200.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, Leerink Partners increased their target price on Align Technology from $210.00 to $225.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Seven analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $198.08.

Align Technology Stock Up 2.2%

NASDAQ:ALGN opened at $176.25 on Tuesday. The business’s 50-day moving average price is $176.54 and its two-hundred day moving average price is $154.06. Align Technology has a twelve month low of $122.00 and a twelve month high of $208.30. The stock has a market cap of $12.56 billion, a P/E ratio of 31.14, a PEG ratio of 1.88 and a beta of 1.79.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 EPS for the quarter, topping the consensus estimate of $2.99 by $0.30. The company had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.Align Technology’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.44 earnings per share. On average, equities research analysts expect that Align Technology will post 7.98 EPS for the current fiscal year.

Insider Activity at Align Technology

In other Align Technology news, EVP John Morici sold 7,969 shares of Align Technology stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at approximately $1,559,346.47. This trade represents a 49.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.66% of the company’s stock.

Institutional Investors Weigh In On Align Technology

A number of institutional investors have recently made changes to their positions in ALGN. Wealth Enhancement Advisory Services LLC grew its position in shares of Align Technology by 38.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 15,551 shares of the medical equipment provider’s stock worth $2,029,000 after buying an additional 4,359 shares during the last quarter. AE Wealth Management LLC bought a new position in shares of Align Technology during the third quarter valued at approximately $650,000. Dana Investment Advisors Inc. purchased a new stake in Align Technology in the third quarter worth $9,991,000. Hussman Strategic Advisors Inc. purchased a new stake in Align Technology in the third quarter worth $3,156,000. Finally, M&G PLC bought a new stake in Align Technology in the third quarter valued at $10,904,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Elliott Investment Management has accumulated a sizable position and plans engagement, raising the prospect of strategic moves to boost shareholder value (cost cuts, buybacks, or portfolio changes). This is the main driver of today’s upside as investors anticipate value-enhancing actions. Elliott builds stake in Invisalign maker – Reuters
• Positive Sentiment: Coverage and market commentary amplified the story (premarket and intraday reports), accelerating buying momentum as retail and institutional traders reacted to the activist news. Align Technology Shares Jump – Benzinga
• Positive Sentiment: Barclays upgraded ALGN to Overweight (price target raised), calling the pullback an improving entry point for investors — a separate catalyst that supports additional buying interest. Align Tech upgraded at Barclays – Seeking Alpha
• Neutral Sentiment: Strategic product/ecosystem updates (e.g., collaborations around iTero and same‑day workflows) reinforce Align’s long-term TAM in digital dentistry but are incremental to the activist-driven move. These partnerships support structural growth but are not an immediate catalyst. Align sees growth prospects in international markets – Yahoo Finance
• Negative Sentiment: Underlying demand has cooled from pandemic highs and ALGN remains far below its 2021 peak, meaning activist moves may be needed to unlock value; operational headwinds (slower dental demand) still pose execution risk if management fails to deliver meaningful improvements. Elliott Builds Major Align Stake as Shares Sit Near $172 – Yahoo Finance

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.